Quris-AI is an artificial intelligence innovator that is disrupting drug development. Its machine-learning bio-platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials. Quris-AI is led by a track-record team of top scientists and strategic investors. Its first AI-based drug is now prepping for clinical testing.
$9M sweet spot round size
$9M
from 2 investors over 1 rounds
Quris AI raised $9M on January 20, 2023
Investors: SoftBank Vision Fund and + 3 Other investors